First Time Loading...

PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 22.6 EUR -1.74%
Updated: May 6, 2024

PharmaSGP Holding SE
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Net Income (Common) Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Net Income (Common)
€12m
CAGR 3-Years
-11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Net Income (Common)
-$40.2m
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Net Income (Common)
-€2.9B
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Net Income (Common)
€2.8B
CAGR 3-Years
12%
CAGR 5-Years
-3%
CAGR 10-Years
9%
MPH Health Care AG
XETRA:93M1
Net Income (Common)
€29.1m
CAGR 3-Years
38%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Net Income (Common)
€62.4m
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Net Income (Common)?
Net Income (Common)
12m EUR

Based on the financial report for Dec 31, 2022, PharmaSGP Holding SE's Net Income (Common) amounts to 12m EUR.

What is PharmaSGP Holding SE's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
0%

Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for PharmaSGP Holding SE have been -11% over the past three years .